Streetbeat News

Stock Prices

CRWD

CrowdStrike has announced its Q3 adjusted EPS guidance of $0.80-$0.81, which is below the estimated $0.96. The company also projects revenue between $979.2 million and $984.7 million, falling short of the $1.01 billion estimate.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 8:10 pm

TOVX

Theriva Biologics shares rose following the announcement of a US patent application notice of allowance for a treatment targeting C. Difficile disease and other antibiotic-induced GI tract adverse effects.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 8:09 pm

AFRM

Affirm Holdings reported better-than-expected Q4 2024 results with an adjusted EPS of $(0.14), beating the estimate of $(0.51). Sales reached $659 million, surpassing the $603.66 million estimate and marking a 47.82% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 8:08 pm

CRWD

CrowdStrike's shares rose following the release of its Q2 financial results, which surpassed expectations.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 8:07 pm

FIVE

Five Below shares rose as the company reported better-than-expected Q2 revenue results.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 8:06 pm

LFVN

Lifevantage reported Q4 2024 earnings per share of $0.14, missing the analyst estimate of $0.21. Sales were $48.931 million, below the expected $50.952 million, and down 9.76% from the previous year.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 8:06 pm

CRM

Salesforce shares are trading higher following the release of better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 8:06 pm

CRWD

CrowdStrike Holdings reported better-than-expected Q2 2025 earnings, with an adjusted EPS of $1.04 surpassing the $0.97 estimate and sales of $963.9 million beating the $958.582 million estimate. This marks a 31.75% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 8:06 pm

NTNX

Nutanix reported Q4 2024 earnings per share of $0.27, surpassing the analyst estimate of $0.20. The company's sales reached $547.95 million, exceeding the expected $536.94 million and marking a 10.87% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 8:05 pm

OKTA

Okta shares are experiencing a decline following the release of their Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 8:05 pm